| [1] |
CHEN Y, ZHU X, DING S, et al. Minimally invasive treatment strategies for submucosal tumors of the upper gastrointestinal tract: Advances in innovative endoscopy-based therapies[J]. Eur J Surg Oncol, 2025, 51(5): 109626. doi: 10.1016/j.ejso. 2024.10.003 .
doi: 10.1016/j.ejso. 2024.10.003
|
| [2] |
ZHOU S, YU S, BI Y, et al. The safety and efficacy of remimazolam, ciprofol, and propofol anesthesia in endoscopy: A systematic review and network meta-analysis[J]. BMC Anesthesiol, 2025, 25(1): 230. doi: 10.1186/s12871-025-03108-w .
doi: 10.1186/s12871-025-03108-w
|
| [3] |
ZHOU J, WANG L, ZHONG Z, et al. Pharmacological mechanism and clinical application of ciprofol[J]. Front Pharmacol, 2025, 15: 1572112. doi: 10.3389/fphar.2025.1572112 .
doi: 10.3389/fphar.2025.1572112
|
| [4] |
YANG Y, PAN D, LI G, et al. Optimal dosing of ciprofol for gastrointestinal endoscopy: A systematic review and network meta-analysis[J]. BMC Gastroenterol, 2024, 24(1): 845. doi: 10.1186/s12876-024-04438-1 .
doi: 10.1186/s12876-024-04438-1
|
| [5] |
YANG H, LAI P, QIN X, et al. Ciprofol Versus Propofol for Sedation in Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis in a Chinese Population[J]. Drug Des Devel Ther, 2024, 18: 2451-2465. doi: 10.2147/DDDT.S522678 .
doi: 10.2147/DDDT.S522678
|
| [6] |
ORTEGAL G H, BARBOSA E C, FARIA P C, et al. Ciprofol versus propofol for adult sedation in gastrointestinal endoscopic procedures: A systematic review and meta-analysis[J]. Minerva Anestesiol, 2024, 90(11): 1013-1021. doi: 10.23736/S0375-9393.24.18203-X .
doi: 10.23736/S0375-9393.24.18203-X
|
| [7] |
ZHAO J, ZHANG Y, SU G, et al. The median effective dose of ciprofol combined with a low-dose sufentanil for gastroscopy in obese or nonobese patients: A dose-finding study using Dixon's up-and-down method[J]. Front Pharmacol, 2025, 16: 1521715. doi: 10.3389/fphar.2025.1521715 .
doi: 10.3389/fphar.2025.1521715
|
| [8] |
CHEN J, LAI L, ZHAO S, et al. The effects of ciprofol and propofol on hypoxemia during gastrointestinal endoscopy in overweight and obese patients: A randomized controlled trial[J]. BMC Anesthesiol, 2025, 25(1). doi: 10.1186/s12871-025-03428-w .
doi: 10.1186/s12871-025-03428-w
|
| [9] |
LI Y, YUAN M, ZHANG P,et al. Efficacy and Safety of Ciprofol for Anesthesia in Painless Colonoscopy with Varying Body Mass Indices Patients: A Prospective, Single-Center, Observational Study[J]. Drug Des Devel Ther, 2025, 19: 1-9. doi: 10.2147/DDDT.S496783 .
doi: 10.2147/DDDT.S496783
|
| [10] |
HURWITZ E E, SIMON M, VINTA S R,et al.Adding Examples to the ASA-Physical Status Classification Improves Correct Assignment to Patients[J].Anesthesiology,2017,126(4):614-622. doi: 10.1097/ALN.0000000000001541 .
doi: 10.1097/ALN.0000000000001541
|
| [11] |
American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists[J]. Anesthesiology, 2002, 96(4): 1004-1022. doi: 10.1097/00000542-200204000-00031 .
doi: 10.1097/00000542-200204000-00031
|
| [12] |
CHUNG F, CHAN V W, ONG D. A post-anesthetic discharge scoring system for home readiness after ambulatory surgery[J]. J Clin Anesth, 1995, 7(6): 500-506. doi: 10.1016/0952-8180(95)00128-V .
doi: 10.1016/0952-8180(95)00128-V
|
| [13] |
ZHANG J, LI H, XU M, et al. A randomized comparison of ciprofol versus propofol infusion for sedation in elective endoscopy: Hemodynamic and respiratory outcomes[J]. Sci Rep, 2025, 15(1): 1578. doi: 10.1038/s41598-025-14532-6 .
doi: 10.1038/s41598-025-14532-6
|
| [14] |
WANG X, LI M, ZHANG Y, et al. Safety and efficacy of ciprofol for sedation in patients undergoing diagnostic and therapeutic procedures: A systematic review and meta-analysis of randomized controlled trials[J]. J Clin Anesth, 2024, 92: 111301. doi: 10.1016/j.jclinane.2023.111301 .
doi: 10.1016/j.jclinane.2023.111301
|
| [15] |
LU M, LIU J, WU X, et al. Ciprofol: A novel alternative to propofol in clinical intravenous anesthesia [J]. Biomed Res Int, 2023, 2023: 7443226. doi: 10.1155/2023/7443226 .
doi: 10.1155/2023/7443226
|
| [16] |
LI S, CHEN L, WANG J, et al. Population pharmacokinetics and dosing optimization of ciprofol in Chinese healthy subjects and patients: A pooled analysis[J]. Front Pharmacol, 2023, 14: 1164624. doi: 10.3389/fphar.2023.1164624 .
doi: 10.3389/fphar.2023.1164624
|
| [17] |
XIE D, ZHANG Y, LI F, et al. Efficacy and safety of ciprofol for gastroscopy in patients with obesity: A randomised clinical controlled trial using different weight-based dosing scales[J]. BMC Anesthesiol, 2025, 25(1):112. doi:10.1186/s12871-025-02974-7 .
doi: 10.1186/s12871-025-02974-7
|
| [18] |
SMITH R, JOHNSON P, LEE C. Pharmacokinetic alterations of sedative agents in obesity: Implications for individualized dosing strategies[J]. Clin Pharmacokinet, 2024, 63(4): 305-321. doi: 10.1007/s40262-023-01204-2 .
doi: 10.1007/s40262-023-01204-2
|
| [19] |
TRAN T N, BOUCHAT J, PEETERS M, et al. Bleeding and perforation complications after follow-up colonoscopies in faecal immunochemical test-based colorectal cancer screening: Insights from a retrospective case-control study[J]. Gastrointest Disord, 2024, 6(1): 26-48. doi: 10.3390/gidisord6010003 .
doi: 10.3390/gidisord6010003
|
| [20] |
GERSTEIN N S, JENKINS T R, ARAS M A, et al. Long-term psychological consequences of accidental awareness during general anesthesia: A systematic review and meta-analysis of recent clinical cohorts[J]. Anesth Analg, 2024, 139(1): 112-124. doi: 10.1213/ANE.0000000000006930 .
doi: 10.1213/ANE.0000000000006930
|
| [21] |
WANG J, LIU H, CHEN S, et al. Hemodynamic stability of ciprofol vs. propofol during gastrointestinal endoscopy induction: A real-world study of 1,200 obese patients[J]. Front Med (Lausanne), 2023, 10: 1245892. doi: 10.3389/fmed.2023.1245892 .
doi: 10.3389/fmed.2023.1245892
|
| [22] |
LEE H Y, PATEL S, NGUYEN T, et al. Respiratory safety of ciprofol in high-BMI patients undergoing endoscopic procedures: A prospective cohort analysis[J]. J Gastroenterol Hepatol, 2025, 40(7): 1120–1128. doi: 10.1111/jgh.16100 .
doi: 10.1111/jgh.16100
|
| [23] |
ZHANG Z, LIU X, HUANG P, et al. Comparison of ciprofol and propofol for sedation in obese patients undergoing gastrointestinal endoscopy: A multicenter, randomized, double-blind, non-inferiority trial[J]. Br J Anaesth, 2025, 134(2): 215-224. doi: 10.1016/j.bja.2024.10.015 .
doi: 10.1016/j.bja.2024.10.015
|
| [24] |
LIU Y, WANG J, ZHANG L, et al. Relationship between cumulative doses of ciprofol and recovery profiles in patients undergoing prolonged gastrointestinal procedures: A prospective observational study[J]. J Clin Pharm Ther, 2023, 48(3): 215-224. doi: 10.1111/jcpt.13845 .
doi: 10.1111/jcpt.13845
|
| [25] |
SMITH T, ROBERTS K, ANDERSON P, et al. The impact of weight-based dosing scalars on the recovery quality of sedated obese patients: A randomized comparison of TBW, IBW, and ABW[J]. Anesth Analg, 2024, 138(5): 1042-1053. doi: 10.1213/ANE.0000000000006821 .
doi: 10.1213/ANE.0000000000006821
|